Sukhjinder Nijjer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sukhjinder nijjer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sukhjinder Nijjer Today - Breaking & Trending Today

Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , City Of , South Essex , United States , Sukhjinder Nijjer , Kevin Cheng , Danqi Wang , Jason Dungu , Sashiananthan Ganesananthan , Raffi Kaprielian , Jonathan Anderson , Jamil Mayet , Iqbal Malik , Juliet Holmes , Craig Robertson , Henry Seligman , Darrel Francis , Ricardo Petraco , Denise Braganza , Michael Foley , Jonathan Hill , Peter Kellman , Gerald Clesham , Tom Johnson , Fiyyaz Ahmed Jushuf , Sayan Sen ,

Funding the Future: How Industry Support for CV Trials Could Evolve


December 17, 2020
When the 5-year results from the controversial EXCEL trial were published earlier this year, it revived an old and divisive stent-versus-surgery debate but it also rekindled questions about how clinical trials are funded. In addition to concerns over trial endpoints and reporting, some physicians complained that EXCEL and other device trials like it can’t be trusted because of the role of the manufacturer in funding the research.
This story is part of
Envision Change
, an end-of-2020 series imagining a different future for cardiology, medicine, research, and health. SEE ALSO: Transforming Clinical Research, Remaking Medicine, Heroes to Human.
The pros and cons of commercial funding in clinical research are well documented, and endless ink has been spent examining the ties between investigators and sponsors and the impact on clinical trials. But what’s the alternative? In a year when so many other aspects of cardiology practice and rese ....

United States , United Kingdom , City Of , Sukhjinder Nijjer , Richard Kovacs , Juan Granada , Andrew Foy , Khurram Nasir , David Brown , American Heart Association , Biomedical Research Centre At Imperial College London , British Cardiovascular Society , Md Washington University School Of Medicine , British Heart Foundation , Phd Imperial College Healthcare , European Society Of Cardiology , Clinical Research , Research Council , Cardiovascular Research Foundation , American College Of Cardiology , British Cardiovascular Intervention Society , Drug Administration , Md Indiana University School Of Medicine , Md Penn State Health , Envision Change , Transforming Clinical ,

GPs likely to see surge in serious heart problems because of COVID lockdown

The COVID-19 lockdown in the first half of 2020 may lead to a surge in heart failure and mechanical heart problems formerly consigned to textbooks, according to a cardiology expert. ....

United Kingdom , City Of , Sukhjinder Nijjer , Hammersmith Hospital , ஒன்றுபட்டது கிஂக்டம் , நகரம் ஆஃப் , சுத்தியல் மருத்துவமனை ,